Effect of olmesartan and pravastatin on experimental cerebral aneurysms in rats

Brain Research

Volumn 1322, Issue , 2010, Pages 144-152

  Kimura, Naoto ^a   Shimizu, Hiroaki ^a   Eldawoody, Hany ^a,b   Nakayama, Toshio ^c   Saito, Atsushi ^a   Tominaga, Teiji ^a   Takahashi, Akira ^a,c  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MANSOURA UNIVERSITY   (Egypt)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Cerebral aneurysm; Experimental; Olmesartan; Pravastatin; Rat

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; HYDRALAZINE; OLMESARTAN; PITAVASTATIN; PRAVASTATIN; SIMVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR CEREBRAL ARTERY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRAIN ARTERY ANEURYSM; CONTROL GROUP; CONTROLLED STUDY; DISEASE COURSE; DRUG ACTIVITY; DRUG EFFECT; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; FEMALE; HISTOLOGY; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; RAT; SACCULAR ANEURYSM; SCANNING ELECTRON MICROSCOPY; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CEREBRAL ARTERIES; CIRCLE OF WILLIS; CORROSION CASTING; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ENDOTHELIAL CELLS; HYDRALAZINE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IMIDAZOLES; INTRACRANIAL ANEURYSM; MICROSCOPY, ELECTRON, SCANNING; PRAVASTATIN; RATS; TETRAZOLES; TREATMENT OUTCOME; VASODILATOR AGENTS;

RATTUS;

EID: 77649233047     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.01.044     Document Type: Article

References (48)

1. Aoki T., Kataoka H., Morimoto M., Nozaki K., and Hashimoto N. Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats. Stroke 38 (2007) 162-169
2. Aoki T., Kataoka H., Shimamura M., Nakagami H., Moriwaki T., Ishibashi R., Nozaki K., Morishita R., and Hashimoto N. NF-kappa B is a key mediator of cerebral aneurysm formation. Circulation 116 (2007) 2830-2840
3. Aoki T., Kataoka H., Ishibashi R., Nozaki K., and Hashimoto N. Simvastatin suppresses the progression of experimentally induced cerebral aneurysms in rats. Stroke 39 (2008) 1276-1285
4. Aoki T., Kataoka H., Ishibashi R., Nozaki K., Egashira K., and Hashimoto N. Impact of monocyte chemoattractant protein-1 deficiency on cerebral aneurysm formation. Stroke 40 (2009) 942-951
5. Aoki T., Kataoka H., Ishibashi R., Nakagami H., Nozaki K., Morishita R., and Hashimoto N. Pitavastatin suppresses formation and progression of cerebral aneurysms through inhibition of the nuclear factor κB pathway. Neurosurgery 64 (2009) 357-366
6. Aoki T., Nishimura M., Kataoka H., Ishibashi R., Nozaki K., and Hashimoto N. Reactive oxygen species modulate growth of cerebral aneurysms: a study using the free radical scavenger edaravone and p47phox(-/-) mice. Lab. Invest. 89 (2009) 730-741
7. Aoki T., Nishimura M., Kataoka H., Ishibashi R., Miyake T., Takagi Y., Morishita R., and Hashimoto N. Role of angiotensin II type 1 receptor in cerebral aneurysm formation in rats. Int. J. Mol. Med. 24 (2009) 353-359
8. Bruno G. Vascular extracellular matrix remodeling in cerebral aneurysms. J. Neurosurg. 89 (1998) 431-440
9. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87 (2000) 840-844
10. Chen X.L., Tummala P.E., Olbrych M.T., Alexander R.W., and Medford R.M. Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ. Res. 83 (1998) 952-959
11. Cruzan G. Assessment of the cancer potential of methanol. Crit. Rev. Toxicol. 39 (2009) 347-363
12. Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation 109 (2004) 39-43
13. De Keulenaer G.W., Ushio-Fukai M., Yin Q., Chung A.B., Lyons P.R., Ishizaka N., Rengarajan K., Taylor W.R., Alexander R.W., and Griendling K.K. Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-alpha-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 385-391
14. Diet F., Pratt R.E., Berry G.J., Momose N., Gibbons G.H., and Dzau V.J. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 94 (1996) 2756-2767
15. Eldawoody H., Shimizu H., Kimura N., Saito A., Nakayama T., Takahashi A., and Tominaga T. Simplified experimental cerebral aneurysm model in rats: comprehensive evaluation of induced aneurysms and arterial changes in the circle of Willis. Brain Res. 1300 (2009) 159-168
16. Fujiwara Y., Shiraya S., Miyake T., Yamakawa S., Aoki M., Makino H., Nishimura M., and Morishita R. Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan. Int. J. Mol. Med. 22 (2008) 703-708
17. Fukuda S., Hashimoto N., Naritomi H., Nagata I., Nozaki K., Kondo S., Kurino M., and Kikuchi H. Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase. Circulation 101 (2000) 2532-2538
18. Hashimoto N., Handa H., Nagata I., and Hazama F. Saccular cerebral aneurysms in rats. Am. J. Pathol. 110 (1983) 397-399
19. Hayashidani S., Tsutsui H., Shiomi T., Suematsu N., Kinugawa S., Ide T., Wen J., and Takeshita A. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 105 (2002) 868-873
20. Hazama F., Kataoka H., Yamada E., Kayembe K., Hashimoto N., Kojima M., and Kim C. Early changes of experimentally induced cerebral aneurysms in rats. Light-microscopic study. Am. J. Pathol. 124 (1986) 399-404
21. Hop J.W., Rinkel G.J., Algra A., and van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage. A systematic review. Stroke 28 (1997) 660-664
22. Imanishi T., Ikejima H., Tsujioka H., Kuroi A., Kobayashi K., Shiomi M., Muragaki Y., Mochizuki S., Goto M., Yoshida K., and Akasaka T. Combined effects of an 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor and angiotensin II receptor antagonist on nitric oxide bioavailability and atherosclerotic change in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits. Hypertens. Res. 31 (2008) 1199-1208
23. Inagawa T. Trends in incidence and case fatality rates of aneurysmal subarachnoid hemorrhage in Izumo City, Japan, between 1980-1989 and 1990-1998. Stroke 32 (2001) 1499-1507
24. Ito T., Yamakawa H., Bregonzio C., Terrn J.A., Falcn-Neri A., and Saavedra J.M. Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist. Stroke 33 (2002) 2297-2303
25. Jamous M.A., Nagahiro S., Kitazato K.T., Tamura T., Aziz H.A., Shono M., Satoh K., and Satomi J. Role of estrogen deficiency in the formation and progression of cerebral aneurysms. Part I: experimental study of the effect of oophorectomy in rats. J. Neurosurg. 103 (2005) 1046-1051
26. Jamous M.A., Nagahiro S., Kitazato K.T., Tamura T., Aziz H.A., Shono M., Satoh K., and Satomi J. Vascular corrosion casts mirroring early morphological changes that lead to the formation of saccular cerebral aneurysm: an experimental study in rats. J. Neurosurg. 102 (2005) 532-535
27. Jamous M.A., Nagahiro S., Kitazato K.T., Tamura T., Aziz H.A., Shono M., and Satoh K. Endothelial injury and inflammatory response induced by hemodynamic changes preceding intracranial aneurysm formation: experimental study in rats. J. Neurosurg. 107 (2007) 410-411
28. Koike H., Sada T., and Mizuno M. In vitro and in vivo pharmacology of olmesartan medoxomil, and angiotensin II type AT1 receptor antagonist. J. Hypertens. 19 (2001) S3-S14
29. Kondo S., Hashimoto N., Kikuchi H., Hazama F., Nagata I., and Kataoka H. Apoptosis of medial smooth muscle cells in the development of saccular cerebral aneurysms in rats. Stroke 29 (1998) 181-188
30. Kubes P., Suzuki M., and Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl Acad. Sci. U. S. A. 88 (1991) 4651-4655
31. Kumai Y., Ooboshi H., Ago T., Ishikawa E., Takada J., Kamouchi M., Kitazono T., Ibayashi S., and Iida M. Protective effects of angiotensin II type 1 receptor blocker on cerebral circulation independent of blood pressure. Exp. Neurol. 210 (2008) 441-448
32. Linn F.H., Rinkel G.J., Algra A., and van Gijn J. Incidence of subarachnoid hemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke 27 (1996) 625-629
33. Marui N., Offermann M.K., Swerlick R., Kunsch C., Rosen C.A., Ahmad M., Alexander R.W., and Medford R.M. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92 (1993) 1866-1874
34. Meng H., Wang Z., Hoi Y., Gao L., Metaxa E., Swartz D., and Kolega J. Complex hemodynamic at the apex of an arterial bifurcation induces vascular remodeling resembling cerebral aneurysm initiation. Stroke 38 (2007) 1924-1931
35. Moriwaki T., Takagi Y., Sadamasa N., Aoki T., Nozaki K., and Hashimoto N. Impaired progression of cerebral aneurysms in interleukin-1beta-deficient mice. Stroke 37 (2006) 900-905
36. Nagata I. Experimentally induced cerebral aneurysms in rats: part IV-cerebral angiography. Surg. Neurol. 12 (1979) 419-424
37. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18 (1999) 6853-6866
38. Radomski M.W., Palmer R.M., and Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 7 (1987) 1057-1058
39. Reidy M.A., and Levesque M.J. A scanning electron microscopic study of arterial endothelial cells using vascular casts. Atherosclerosis 28 (1977) 463-470
40. Ruiz-Ortega M. Role of the renin-angiotensin system in vascular disease: expanding the field. Hypertension 38 (2001) 1382-1387
41. Sadamasa N., Nozaki K., and Hashimoto N. Disruption of gene for inducible nitric oxide synthase reduces progression of cerebral aneurysms. Stroke 34 (2003) 2980-2984
42. Stehbens W.E. Etiology of intracranial berry aneurysms. J. Neurosurg. 70 (1989) 823-831
43. Tada Y., Kitazato K.T., Tamura T., Yagi K., Shimada K., Kinouchi T., Satomi J., and Nagahiro S. Role of mineralocorticoid receptor on experimental cerebral aneurysms in rats. Hypertension 54 (2009) 552-557
44. Tamura T., Jamous M.A., Kitazato K.T., Yagi K., Tada Y., Uno M., and Nagahiro S. Endothelial damage due to impaired nitric oxide bioavailability triggers cerebral aneurysm formation in female rats. J. Hypertens. 27 (2009) 1284-1292
45. Tummala P.E., Chen X.L., Sundell C.L., Laursen J.B., Hammes C.P., and Alexander R.W. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis. Circulation 100 (1999) 1223-1229
46. van Gijn J., Kerr R.S., and Rinkel G.J. Subarachnoid haemorrhage. Lancet 27 (2007) 306-318
47. Vasa M., Fichtlscherer S., Adler K., Aicher A., Martin H., Zeiher A.M., and Dimmeler S. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103 (2001) 2885-2890
48. Yamamoto E., Yamashita T., Tanaka T., Kataoka K., Tokutomi Y., Lai Z.F., Dong Y.F., Matsuba S., Ogawa H., and Kim-Mitsuyama S. Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 556-563